Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition.
Schreiber
W
W
Krieg
J C
JC
Eichhorn
T
T
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine; D013747:Tetrabenazine / Q000009:adverse effects*
D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine; D013747:Tetrabenazine